Feb. 17 at 3:22 PM
$BCTX A few more days and it'll be time for another swing trade buy again. Prior to the most recent offering, the market cap hovered around
$20 mil, give or take a couple mil, so that equates to
$3.23 or so a share. Not sure we get there, but if we do, that'd be a strong spot IMO.
Right around the beginning of March last year was where price bottomed before the run-up into AACR and ASCO. Price action continues to be horrible overall, but the cash runway is there now to support a swing long into the spring conferences with no fear of a "have to in order to stay alive" offering.
Of course, still eyeing interim data as the ultimate catalyst in either direction later this year (likely late summer IMO).
